Bcl-3 expression and nuclear translocation are induced by granulocyte- macrophage colony-stimulating factor and erythropoietin in proliferating human erythroid precursors

Blood

Volumn 92, Issue 4, 1998, Pages 1225-1234

  Zhang, Min Ying ^a   Harhaj, Edward W ^a   Bell, Laurie ^a   Sun, Shao Cong ^a   Miller, Barbara A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LUCIFERASE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ERYTHROID PRECURSOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTO ONCOGENE; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 0032529492     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1225.416k20_1225_1234     Document Type: Article

References (44)

1. Ohno H, Takimoto G, McKeithan TW: The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991, 1990
2. Zhang Q, Didonato JA, Karin M, McKeithan TW: BCL3 encodes a nuclear protein which can alter the subcellular location of NF-κB proteins. Mol Cell Biol 14:3915, 1994
3. Nolan GP, Fujita T, Bhatia K, Huppi C, Liou H-C, Scott ML, Baltimore D: The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol 13:3557, 1993
4. Caamano JH, Ferez P, Lira SA, Bravo R: Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol Cell Biol 16:1342, 1996
5. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405, 1994
6. Liou H-C, Baltimore D: Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr Opin Cell Biol 5:477, 1993
7. Thanos D, Maniatis T: NF-κB: A lesson in family values. Cell 80:529, 1995
8. Beg AA, Baldwin AS: The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 7:2064, 1993
9. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U: The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729, 1993
10. Fujita T, Nolan GP, Liou H-C, Scott ML, Baltimore D: The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 7:1354, 1993
11. Pan J, McEver RP: Regulation of the human P-selection promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family. J Biol Chem 270:23077, 1995
12. Franzoso G, Bours V, Azarenko V, Park S, Tomita-Yamaguchi N, Kanno T, Brown K, Siebenlist U: The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J 12:3893, 1993
13. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao Y-F, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989
14. Miller BA, Floros J, Cheung JY, Wojchowski DM, Bell L, Begley CG, Elwood NJ, Kreider J, Christian C: Steel factor affects SCL expression during normal erythroid differentiation. Blood 84:2971, 1994
15. Braylan RC, Benson NA, Noursa V, Kruth HS: Correlated analyses of cellular DNA, membrane antigens, and light scatter of human lymphoid cells. Cytometry 2:337, 1982
16. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
17. Sun S-C, Ganchi PA, Ballard DW, Greene WC: NF-κB controls expression of inhibitor IκBα: Evidence for an inducible autoregulatory pathway. Science 259:1912, 1993
18. Stein B, Rahmsdorf H, Steffen A, Litfin M, Herrlich P: UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol 9:5169, 1989
19. Sun S-C, Elwood J, Greene WC: Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol Cell Biol 16:1058, 1996
20. Ganchi PA, Sun S-C, Greene WC, Ballard DW: IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol Biol Cell 3:1339, 1992
21. Sun S-C, Ganchi PA, Beraud C, Ballard DW, Greene WC: Autoregulation of the NF-κB p65 transactivator by multiple ankyrin-rich cytoplasmic inhibitors. Proc Natl Acad Sci USA 91:1346, 1994
22. Maggirwar SB, Harhaf EW, Sun S-C: Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors. Mol Cell Biol 17:2605, 1997
23. Harhaj EW, Maggirwar SB, Good L, Sun S-C: CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol Cell Biol 16:6736, 1996
24. Sun S-C, Faye I: Affinity purification and characterization of GIF, an insect immunoresponsive factor with NF-κB-Iike properties. Comp Biochem Physiol 103B:225, 1992
25. Condorelli G, Vitelli L, Valtieri M, Marta I, Montesoro E, Lulli V, Baer R, Peschle C: Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood 86:164, 1995
26. Zhang M-Y, Sun S-C, Bell L, Miller BA: NF-κB transcription factors are involved in normal erythropoiesis. Blood 91:4136, 1998
27. Emilia G, Donelli A, Ferrari S, Torelli U, Selleri L, Zucchini P, Moretti L, Venturelli D, Ceccherelli G, Torelli G: Cellular levels of mRNA from c-myc, c-myb and c-fes one-genes in normal myeloid and erythroid precursors of human bone marrow: An in situ hybridization study. Br J Haematol 62:287, 1986
28. Caracciolo D, Venturelli D, Valtieri M, Peschle C, Gewirtz AM, Calabretta B: Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis. J Clin Invest 85:55, 1990
29. Kirsch ER, Bertness V, Silver J, Hollis GF: Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. J Cell Biochem 32:11, 1986
30. Valtieri M, Venturelli D, Care A, Fossati C, Pelosi E, Labbaye C, Mattia G, Gewirtz AM, Calabretta B, Peschle C: Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase a. Blood 77:1181, 1991
31. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369, 1995
32. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
33. Wakao H, Harada N, Kitamura T, Mui AL-F, Miyajima A: Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 14:2527, 1995
34. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen L-A, Norstedt G, Levy D, Groner B: Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J 14:2005, 1995
35. Carroll MP, Spivak JL, McMahon M, Weich N, Rapp UR, May WS : Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem 266:14964, 1991
36. Bittorf T, Jaster R, Brock J: Rapid activation of the MAP kinase pathway in hematopoietic cells by erythropoietin, granulocyte-macrophage colony-stimulating factor and interleukin-3. Cell Signal 6:305, 1994
37. Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 80:575, 1992
38. Chiba T, Nagata Y, Kishi A, Sakamaki K, Miyajima A, Yamamoto M, Engel JD, Todokoro K: Induction of erythroid-specific gene expression in lymphoid cells. Proc Natl Acad Sci USA 90:11593, 1993
39. Robb L, Lyons I, Li R, Hartley L, Kontgen F, Harvey RP, Metcalf D, Begley CG: Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 92:7075, 1995
40. Zhang M-Y, Clawson GA, Olivieri NF, Bell LL, Begley CG, Miller BA: Expression of SCL is normal in transfusion-dependent Diamond-Blackfan anemia but other bHLH proteins are deficient. Blood 90:2068, 1997
41. Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH: Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362:722, 1993
42. Osada H, Grutz G, Axelson H, Forster A, Rabbitts TH: Association of erythroid transcription factors: Complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA 1. Proc Natl Acad Sci USA 92:9585, 1995
43. Hsu H-L, Huang L, Tsan JT, Funk W, Wright WE, Hu J-S, Kingston RE, Baer R: Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14:1256, 1994
44. Shivdasani RA, Mayer EL, Orkin SH: Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373:432, 1995